Advent to take minority stake in Ireland's Felix Pharmaceuticals

The firm will invest $175 million in Felix via primary and secondary.

9 June 2025•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.